Today: 20 May 2026
Dow Inc stock jumps, then steadies in premarket as analysts reset targets ahead of earnings
9 January 2026
1 min read

Dow Inc stock jumps, then steadies in premarket as analysts reset targets ahead of earnings

New York, Jan 9, 2026, 07:40 (EST) — Premarket

Dow Inc (DOW) shares were up 0.15% at $25.96 in Friday premarket action, following a 4.52% jump that left the chemical maker at $25.92 by the prior session’s close.

The shift comes as investors hunt for any indication the U.S. chemicals slump may be letting up, at least in certain areas. Bank of America lowered its price target on Dow to $25 from $26 and maintained a neutral rating, cautioning that commodity chemicals — bulk products that tend to trade on supply and demand — are dealing with “growing oversupply,” and that some anticipated catalysts are “too new to rely on.” TipRanks

Dow beat several close peers in Thursday trading, as Linde gained 1.28% and DuPont rose 0.39% while Air Products edged down 0.25%, according to MarketWatch data. Still, even with the pop, Dow’s shares were roughly 39% under their 52-week high.

Mizuho analyst John Roberts lifted his price target on Dow to $27 from $25 and maintained a Neutral rating, pointing to recent shifts in the market. A price target is a broker’s estimate of where a stock could trade over the next year.

Risk sentiment still hinged on the U.S. employment backdrop, as markets zeroed in on Friday’s December nonfarm payrolls report. The numbers can rapidly reset rate-cut expectations, and that shift often spills over into cyclical shares tied to manufacturing demand.

Dow’s next major company-specific event is its fourth-quarter earnings release and conference call on Jan. 29 at 8:00 a.m. ET, as listed on its investor events calendar.

Investors will be tuning in for remarks on plastics pricing, whether customers are rebuilding inventories, and any updates on operating rates and cost actions. For Dow, the outlook can matter more than the quarter.

The setup can swing either way, though. If demand remains uneven or supply continues to build, any price pop can reverse quickly once the regular session starts and trading volume picks up.

The first hurdle comes at 8:30 a.m. ET, when the Labor Department publishes the Employment Situation report for December 2025. Then the spotlight shifts to Dow’s Jan. 29 earnings release and call.

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Nvidia stock slips before the bell as China H200 payment terms jolt AI stocks
Previous Story

Nvidia stock slips before the bell as China H200 payment terms jolt AI stocks

Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now
Next Story

Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now

Go toTop